Language menu:
AAA appoints two additional Board Members - January 2010
AAA announces the production and commercialisation of a new radiopharmaceutical in France - November 2009
AAA awarded by Deloitte Fast Technology 50 as the fastest growing technology company in Rhône-Alpes Auvergne Region - October 2009
GiPharma acquires a new licence in France - September 2009
AAA to support University of Lausanne Hospitals - September 2009
AAA enters SNM Clinical Trials Network - August 2009
Maurizio Mariani is the new Head of R&D - April 2009
AAA to manage THERANEAN project with Lyonbiopôle - March 2009
AAA Italy gets the authorizations to handle transportations - February 2009
AAA acquires Italian pharma manufacturer GiPharma - January 2009
AAA network
Advanced Accelerator Applications (AAA) has a unique platform of laboratories for the research, development, production and distribution of radiopharmaceuticals for molecular diagnostics and therapy, aiming at a personalized treatment of serious diseases.
Products
AAA is a European leader in the production and commercialization of PET (Positron Emission Tomography) and SPECT (Single Photon Emission Tomography) radiopharmaceuticals and is able to produce and deliver both commercial drugs and research products.